SEC-sourced researchBeta
BRGX
BIOREGENX, INC.
Company comparison ↗
Data passport
- CIK
- 0001593184
- Exchange
- OTC
- Business activity
- — · SIC 7370
- Financial inputs
- 6/6
- Filing date
- Apr 15, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 2,340,106.0000 | Apr 15, 2026 |
| December 2025 | 1,854,513.0000 | Apr 15, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,854,513.0000 | -1,543,569.0000 | 38,972.0000 | 410,986.0000 | 4,948,240.0000 | Apr 15, 2026 |
| December 2024 | 2,340,106.0000 | -23,054,017.0000 | -324,148.0000 | 508,535.0000 | 3,887,794.0000 | Apr 15, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.85M | December 2025 | Apr 15, 2026 | 10-K |
| Previous period revenueRevenues | $2.34M | December 2024 | Apr 15, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$1.54M | December 2025 | Apr 15, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $38.97K | December 2025 | Apr 15, 2026 | 10-K |
| Total assetsAssets | $410.99K | December 2025 | Apr 15, 2026 | 10-K |
| Total liabilitiesLiabilities | $4.95M | December 2025 | Apr 15, 2026 | 10-K |